Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | GS-5829 |
Trade Name | |
Synonyms | Alobresib|GS5829|GS 5829 |
Drug Descriptions |
Alobresib (GS-5829) is a BET bromodomain inhibitor, potentially resulting in inhibition of cell growth and apoptotic activity (Blood 2016 128:5104, PMID: 29941483, PMID: 31862959). |
DrugClasses | BET Inhibitor (Pan) 32 |
CAS Registry Number | 1637771-14-2 |
NCIT ID | C126640 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Exemestane + GS-5829 | Exemestane GS-5829 | 0 | 3 |
Fulvestrant + GS-5829 | Fulvestrant GS-5829 | 0 | 1 |
GS-5829 | GS-5829 | 0 | 0 |
GS-5829 + Venetoclax | GS-5829 Venetoclax | 0 | 0 |